Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Ivermectina: revisão da Cochrane mais comentada de todos os tempos, até agora. Por quê?

17 Set, 2021 | 12:07h

Ivermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library

Revisão original: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

 

Comentário no Twitter

 

Relatório do CDC mostra que pessoas não vacinadas são 11 vezes mais propensas a morrer de COVID-19.

17 Set, 2021 | 12:05h

Unvaccinated People Are 11 Times More Likely To Die Of COVID-19, New Research Finds – NPR

Estudo original: Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 – CDC Morbidity and Mortality Weekly Report

 

Comentário no Twitter

 

A intrincada história das vacinas de mRNA.

17 Set, 2021 | 12:02h

The tangled history of mRNA vaccines – Nature

Conteúdos relacionados:

mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.

 

Comentário no Twitter

 

Como a COVID está atrapalhando a luta contra HIV, tuberculose e malária.

17 Set, 2021 | 12:01h

How COVID is derailing the fight against HIV, TB and malaria – Nature

Conteúdos relacionados:

How COVID hurt the fight against other dangerous diseases

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

Revisão conclui que a eficácia da vacina contra COVID-19 não dá suporte a doses de reforço para a população geral.

14 Set, 2021 | 14:31h

Comunicado de imprensa: COVID-19 vaccine efficacy does not support boosters for general population, review concludes – The Lancet

Artigo original: Considerations in boosting COVID-19 vaccine immune responses – The Lancet

Comentários:

FDA experts among group opposing US booster shot plan – Associated Press

FDA vaccine regulators argue against Covid-19 vaccine boosters in new international review – STAT

Global experts pan wider use of COVID vaccine booster dose – CIDRAP

Expert reaction to viewpoint article on COVID-19 booster vaccines for general populations – Science Media Centre

Boosters Are ‘Not Appropriate’ – Reach Unvaccinated First – Health Policy Watch

Data Doesn’t Support Need for COVID-19 Vaccine Boosters: Experts – HealthDay

In a new review, some F.D.A. scientists and others say boosters aren’t needed for the general population. – The New York Times

Relatório | Pessoas plenamente vacinadas respondem por 1,2% das mortes por Covid-19 na Inglaterra.

14 Set, 2021 | 14:29h

Fully vaccinated people account for 1.2% of England’s Covid-19 deaths – The Guardian

Relatório original: Deaths involving COVID-19 by vaccination status, England: deaths occurring between 2 January and 2 July 2021 – Office for National Statistics

Covid: experts do Reino Unido recomendam vacina com única dose para crianças de 12 a 15 anos de idade.

14 Set, 2021 | 14:28h

Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors – BBC

Ver também: Covid-19: Children aged 12-15 should be offered vaccine, say UK’s chief medical officers – The BMJ

Revisão | A próxima fase da vigilância do SARS-CoV-2: epidemiologia molecular em tempo real.

14 Set, 2021 | 14:26h

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology – Nature Medicine

 

Comentário no Twitter

 

Números expressivos de novas infecções por COVID-19, e não as vacinas, são os principais motivadores das novas variantes do coronavírus.

14 Set, 2021 | 14:25h

Massive numbers of new COVID–19 infections, not vaccines, are the main driver of new coronavirus variants – The Conversation

Vacinas não produzirão variantes piores.

14 Set, 2021 | 14:23h

Vaccines Will Not Produce Worse Variants – Science

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.